NasdaqCM - Delayed Quote USD

IRADIMED CORPORATION (IRMD)

41.00 +0.64 (+1.59%)
At close: April 19 at 4:00 PM EDT
41.00 0.00 (0.00%)
After hours: April 19 at 4:03 PM EDT
Loading Chart for IRMD
DELL
  • Previous Close 40.36
  • Open 40.18
  • Bid 40.65 x 100
  • Ask 41.37 x 100
  • Day's Range 40.18 - 41.41
  • 52 Week Range 36.12 - 51.04
  • Volume 46,135
  • Avg. Volume 55,503
  • Market Cap (intraday) 519.232M
  • Beta (5Y Monthly) 0.86
  • PE Ratio (TTM) 30.37
  • EPS (TTM) 1.35
  • Earnings Date May 2, 2024 - May 6, 2024
  • Forward Dividend & Yield 0.15 (0.37%)
  • Ex-Dividend Date Dec 21, 2023
  • 1y Target Est 59.00

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

www.iradimed.com

148

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IRMD

Performance Overview: IRMD

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IRMD
13.63%
S&P 500
4.14%

1-Year Return

IRMD
3.01%
S&P 500
19.55%

3-Year Return

IRMD
68.63%
S&P 500
18.68%

5-Year Return

IRMD
67.59%
S&P 500
70.99%

Compare To: IRMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IRMD

Valuation Measures

As of 4/18/2024
  • Market Cap

    511.13M

  • Enterprise Value

    463.41M

  • Trailing P/E

    29.90

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.83

  • Price/Book (mrq)

    7.16

  • Enterprise Value/Revenue

    7.07

  • Enterprise Value/EBITDA

    22.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.22%

  • Return on Assets (ttm)

    14.10%

  • Return on Equity (ttm)

    23.70%

  • Revenue (ttm)

    65.56M

  • Net Income Avi to Common (ttm)

    17.19M

  • Diluted EPS (ttm)

    1.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.76M

  • Total Debt/Equity (mrq)

    2.86%

  • Levered Free Cash Flow (ttm)

    8.4M

Research Analysis: IRMD

Analyst Price Targets

56.00
59.00 Average
41.00 Current
61.00 High
 

Fair Value

Undervalued
% Return
41.00 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch